ANZUP actively fosters, collaborates, and expands its relationships with stakeholders through diverse avenues. Notably, the funding agreement with the Australian Government via Cancer Australia Support for Cancer Clinical Trials remains pivotal in supporting ANZUP’s infrastructure.

Donors, volunteers, philanthropists, corporate partners, and other key stakeholders remain a significant focus for ANZUP, particularly within the Partnerships and Engagement role. ANZUP continues to cultivate, oversee, and nurture these vital relationships.

Collaborative partnerships have been instrumental in enabling ANZUP to function at a high capacity. This is demonstrated by the four trials with other Cancer Cooperative Trials Groups (CCTGs) and our involvement in the Executive Officers Network (EON) and Clinical Trials Consumer Network (CTCN). The CTCN shares information amongst the groups’ Consumer Advisory Panels (CAPs) and EON reinforces links between groups by the sharing of concepts and resources.

In 2023/24, ANZUP collaborated with the NHMRC Clinical Trials Centre (CTC) at the University of Sydney on 15 clinical trials. Additionally, ANZUP partnered with the Centre for Biostatistics and Clinical Trials (BaCT) for 4 clinical trials, the Walter and Eliza Hall Institute of Medical Research (WEHI) for 1 trial, the Hunter Medical Research Institute (HMRI) for 1 trial, and The George Institute for Global Health (TGI) for 2 trials. These established affiliations guarantee vigorous processes on trial development and operations.